Kineta - 53 Year Dividend History | KANT
Historical dividend payout and yield for Kineta (KANT) since 1971. The current TTM dividend payout for Kineta (KANT) as of September 18, 2024 is $0.00. The current dividend yield for Kineta as of September 18, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.005B |
|
Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based in Seattle.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
